A randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas cardiomyopathy

This publication has 30 references indexed in Scilit:

• Early Detection by the Tei Index of Carvedilol-Induced Improved Left Ventricular Function in Patients With Heart Failure
  The American Journal of Cardiology, 2005
• Carvedilol therapy is associated with a sustained decline in brain natriuretic peptide levels in patients with congestive heart failure
  American Heart Journal, 2005
• Brain natriuretic peptide response is heterogeneous during β-blocker therapy for congestive heart failure
  Journal of Cardiac Failure, 2004
• ACORDES trial – brazilian multicentre open label study with carvedilol to demonstrate efficacy and safety in patients with chronic heart failure, including a pilot subgroup with chagas disease
  Journal of Cardiac Failure, 2003
• Congestive heart failure: a half century perspective
  European Heart Journal, 2001
• SF-36 Health Survey Update
  Spine, 2000
• Acute effects of digitalis and enalapril on the neurohormonal profile of chagasic patients with severe congestive heart failure
  International Journal of Cardiology, 1996
• The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
  New England Journal of Medicine, 1996
• Effects of Enalapril on Mortality in Severe Congestive Heart Failure
  New England Journal of Medicine, 1987
• Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.
  Circulation, 1978